Showing posts with label hCoV-EMC. Show all posts
Showing posts with label hCoV-EMC. Show all posts

Thursday, May 02, 2013

Saudi Press Release On Novel Coronavirus (nCoV-EMC) Cases

image

Coronavirus – Credit CDC PHIL

 

# 7216

 

 

My thanks to Gregory Hartl, spokesperson for the World Health Organization, for the link to the Saudi Press release on the seven new novel coronavirus cases (see hCoV-EMC: Saudi Arabia Reports 7 Cases, 5 Fatal).

 

 

What follows is a machine translation from the original Arabic.

 

“Health" monitor seven cases of HIV Coruna five people have died

Riyadh 21 Jumada II 1434 H corresponding to May 1, 2013, SPA


Announced the Ministry of Health Monitoring (7) cases of infection Corona new during the past few days in the province of Al-Ahsa, died, including five people, two in intensive care.

 

The ministry said in a statement released by the evening that The Ministry of Health is doing all the precautionary measures for Mkhaltin for people by routers scientific local and global sampling of them to see if there are cases among them, indicating that it recorded so far 17 confirmed cases of the disease worldwide.

 

Showed that the virus Corona is one of the viruses that infect the respiratory tract, accounting for 15% of the viruses that cause influenza in humans, while the longer this pattern a new not yet exist at the level of the world accurate information about the source of this virus and its modes of transmission, as there is no vaccination and preventive or antibiotic treatment for the virus.

hCoV-EMC: Saudi Arabia Reports 7 Cases, 5 Fatal

Coronavirus

Photo Credit NIAID

UPDATED: Confirmed at 7:20am EDT by Gregory Hartl, spokesperson for WHO.

image

 

# 7214

 

It’s being widely reported this morning (see Reuters, AFP, Al Jazeera stories) that 5 Saudis have died in recent days from the novel coronavirus (hCoV-EMC aka NCoV), and that two more remain in Intensive Care.

 

Caveat: Thus far, I’ve not been able to find an official announcement from the KSA Ministry of Health. All of the media reports read as if they are based on the same report, and so I’ve been trying (without success) to find alternate corroboration (see UPDATE above).

 

Crucial details - such as patient descriptions, onset dates, and epidemiological links (if any)  - are not provided at this time.  About all we really know are the numbers, and a generic location (Ahsaa province).

 

First, a report from Al Jazeera, then I’ll return with a bit more.

 

Five die of SARS-like virus in Saudi Arabia

Health ministry says it is taking "precautionary measures" with two more people being treated in intensive care unit.

Last Modified: 02 May 2013 08:31

Saudi Arabia's health ministry has said that five Saudis have died from a new SARS-like virus and that two more are being treated in an intensive care unit.

 

In a statement cited by the Saudi SPA agency late on Wednesday, the ministry said that all the deaths occurred in the Ahsaa province in the oil-rich eastern region of the kingdom, according to the AFP news agency.

 

Known as novel coronavirus or hCoV-EMC, the virus was first detected in mid-2012 and is a cousin of Severe Acute Respiratory Syndrome (SARS), which triggered a scare 10 years ago when it erupted in east Asia, leaping to humans from animal hosts.

 

The health ministry said it was taking "all precautionary measures for persons who have been in contact with the infected people ... and has taken samples from them to examine if they are infected".

 

However, the ministry gave no figures for how many people have been examined to see if they have the lethal disease.

(Continue . . .)

 

This novel coronavirus (hCoV-EMC) appeared just over a year ago in a cluster of patients at a Jordanian Hospital, since then, there have been 17 lab confirmed cases, and roughly a dozen `suspected’ cases.   

 

While a couple of `mild’ cases have been reported, most of the known hCoV-EMC cases have progressed to severe pneumonia, and renal failure.  Until today, 12 of the 17 confirmed cases have proved fatal.

 

Four  clusters support the idea that some, limited, human-to-human transmission has occurred.

 

Although the H7N9 virus had temporarily pushed this novel coronavirus off the front page, pretty much everyone in the EID world has been expecting that more cases would crop up. 

 

The World Health Organization – in their recent GAR (Global Alert & Response) update of April 24th, described the current status of the NCoV Investigations this way:

 

 

Novel coronavirus summary and literature update – as of 24 April 2013

Summary

The available evidence related to novel coronavirus continues to suggest a zoonotic origin for the virus. However, the cluster of cases reported by the United Kingdom provides strong evidence of human-to-human transmission, confirming suspicions that were raised in the previously reported clusters. Investigations around cases have not thus far uncovered evidence of sustained transmission in the community, and transmission between humans appears to be relatively uncommon. The availability of serological tests and the recently acquired capacity to test for the virus using sensitive PCR techniques provide an opportunity to expand our knowledge of the occurrence of the virus in the community.

 

Many questions remain to be answered. The most important are the source of the virus, the exposures that result in human infection, and the mode of transmission. Some features of the cases such as the predominance of males among the confirmed cases may provide important clues to relevant exposures. In addition, although all cases to date have had some connection with the Arabian peninsula, more information is needed about the true geographic extent of the virus. Available evidence suggests that the virus may have its origin in bat species. However, experience with Nipah virus in Malaysia and SARS in China both illustrate that intermediate hosts may sometimes play an important role in transmission to humans and that direct exposure to reservoir species is not needed for infection. The experience of Nipah virus in Bangladesh, in which consumption of raw palm sap contaminated by bat feces has been identified as the mode of transmission, also illustrates the sometimes complex route by which virus may be transmitted from source to human. Finally, if more cases occur, it will be important to study clinical management methods in light of new research demonstrating the effect of certain antiviral agents on laboratory growth of the virus. Protocols for clinical management trials should be developed in anticipation of future cases.

 

In addition to the kinds of investigations described above, there continues to be a need for vigilance and surveillance, both within the affected area and for unusual clusters of respiratory disease in other parts of the world.

Wednesday, March 13, 2013

Nature: Receptor For NCoV Found

Coronavirus

Photo Credit NIAID

 

# 7004

 

A fairly technical report appears in the Journal Nature  today - produced by research teams in both Europe and Saudi Arabia - that establishes the mechanism by which the novel Coronavirus NCoV (here called hCoV-EMC) binds to, and infects, mammalian cells.

 

They found this novel coronavirus uses a well known cell surface protein called dipeptidyl peptidase 4 (DPP4) to enter and infect human cells. 

 

This DPP4 cell surface protein (also called CD26) is evolutionarily conserved in other species, including bats (suspected of being potential species), non-human primates, and other animals – all of which suggests that this virus might be able to infect a wide range of hosts.

 

Working in vitro with Vero & COS-7 cells (African Green Monkey kidneys), Huh-7 (human hepato-carcinoma) and kidney cells of the P. pipistrellus bat, researchers found how hCoV-EMC’s receptor-binding domain latched onto cells. 

 

Using protein-specific antibodies, they were able to block specific receptors, systematically narrowing the field of possible attachment sites.

 

When DPP4 proteins were blocked, the virus was no longer able to attach to cells and cause infection. A discovery that could potentially lead to some specific treatment for this virus down the line.

 

These are, of course, early days.  And we still know very little about the origin – and the potential – of this virus.

 

The researchers point out that (in humans) DPP4 is primarily expressed by epithelial cells in the in kidney, small intestine, liver and prostate. They also observed that DPP4 is expressed by non-ciliated bronchial epithelial cells of the respiratory tract.

 

Locations consistent with the clinical picture of infection we’ve seen over the past year, that has often included both pneumonia and renal failure.

 

Declan Butler at Nature has far more on all of this, after which you’ll find a link to the study.

 

Receptor for new coronavirus found

Virus might have many animal reservoirs.

Declan Butler 13 March 2013

 

 

And the study’s abstract can be found at:

 

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

V. Stalin Raj, Huihui Mou, Saskia L. Smits, Dick H. W. Dekkers, Marcel A. Müller, Ronald Dijkman, Doreen Muth, Jeroen A. A. Demmers, Ali Zaki, Ron A. M. Fouchier, Volker Thiel, Christian Drosten, Peter J. M. Rottier, Albert D. M. E. Osterhaus, Berend Jan Bosch & Bart L. Haagmans

Tuesday, December 11, 2012

mBio: Coronavirus Has An Affinity For Multiple Hosts

 

Coronavirus

Photo Credit NIAID


# 6772

 

Most of the infectious diseases that afflict mankind today began in a different animal species, but jumped to humans and then adapted to our physiology.  

 

  • The scourge of Tuberculosis, which now infects 1/3rd of humanity, likely jumped species when man began to corral and raise its traditional hosts; goats and cattle.
  • Measles appears to have evolved from canine distemper and/or the Rinderpest virus of cattle.  
  • Influenza, as most of you know, is native to aquatic birds – but jumped species thousands of years ago and many strains have adapted to humans, pigs, and other species.

 

The list of zoonotic diseases (those shared between humans and animals) is long and continually expanding, and includes: SARS, Babesiosis, Borrelia (Lyme), Nipah, Hendra, Malaria, Hantavirus, Ebola, Bartonella, Leptospirosis, Q-Fever, bird flu and many, many others

 

Most viruses are fairly selective about the type of cells they will invade, what organ systems they will attack, and even what species they will infect.

 

Horse viruses generally attack equines, and not say, cats and dogs.   Cat viruses tend to attack felines, and not birds.  Bird viruses usually only infect avian species.

 

But some viruses are more promiscuous than others.

Rabies can infect nearly all warm-blooded animals, and we’ve seen the H5N1 `avian flu’ virus infect a wide range of mammals, including humans, dogs, cats, and pigs.

 

Later today, mBio®, the online open-access journal of the American Society for Microbiology, will publish a study that looks at the host range of the newly discovered coronavirus (hCoV-EMC) in the Middle East.


Although researchers are still looking for the receptor cell that allows entry of the virus into the host’s cells, they have found that the hCoV-EMC virus can infect a number of bat species, along with pigs, and of course, humans.

 

We’ll have to wait a few hours to see the study, but the ASM has a press release with some of the details, and we also have an excellent write up by Helen Branswell of the Canadian Press.

 

First, excerpts from the press Release

Public release date: 11-Dec-2012

New coronavirus has many potential hosts, could pass from animals to humans repeatedly

The SARS epidemic of 2002-2003 was short-lived, but a novel type of human coronavirus that is alarming public health authorities can infect cells from humans and bats alike, a fact that could make the animals a continuing source of infection, according to a study to be published in in mBio®, the online open-access journal of the American Society for Microbiology, on December 11. The new coronavirus, called hCoV-EMC, is blamed for five deaths and several other cases of severe disease originating in countries in the Middle East.

 

According to the new results, hCoV-EMC uses a different receptor in the human body than the SARS virus, and can infect cells from a wide range of bat species and pigs, indicating there may be little to keep the virus from passing from animals to humans over and over again.

 

First identified in a patient in Saudi Arabia in June, nine laboratory-confirmed cases of hCoV-EMC infection have now been identified, five of whom have died. Although the virus does not apparently pass from person-to-person very readily, the case fatality rate and the fact that the source of the virus has not been identified have caused concern among global public health authorities. Cases of hCoV-EMC infection are marked by severe pneumonia and often by kidney failure.

 

"This virus is closely related to the SARS virus, and looking at the clinical picture, it causes the same pattern of disease," says Christian Drosten of the University of Bonn Medical Centre in German, a lead author of the study.

 

Given the similarities, Drosten and his colleagues wanted to know whether hCoV-EMC and SARS might use the same receptor, a sort of molecular "dock" on human cells that the virus latches onto to gain entry to the cell. The SARS receptor, called ACE2, is found mostly on pneumocytes deep within the human lung, so an individual must breathe in many, many SARS viruses for a sufficient number of them to reach this susceptible area and cause an infection. Drosten says this simple fact helped ensure the SARS outbreak didn't spread like wildfire and was mostly limited to healthcare workers and residents of overcrowded housing in Hong Kong. Also, once a person was infected with SARS in the deep part of their lungs, he or she felt sick almost immediately and therefore was not active in the community and infecting others, another aspect of the receptor that helped curb the outbreak.

 

Does hCoV-EMC use the same receptor? If so, the means of controlling this new virus might become clearer.

 

"The answer is a clear no," says Drosten. "This virus does not use ACE2." This leaves open the possiblity that hCoV-EMC could use a receptor in the human lung that is easier to access and could make the virus more infectious than SARS, but it is still not known what receptor the virus does use.

 

To help identify how hCoV-EMC might have originated and moved between humans and animals, the second part of the study focused on the animal species the virus can infect. SARS is closely related to viruses from bats, but Drosten says the virus changed in the transition from bats to civet cats to humans and could no longer infect bats, so SARS was not present in the wild and did not pass repeatedly from bats to humans like a classical zoonotic disease. "So the [SARS] virus lost its old host and gained a new one," says Drosten.

 

Like SARS, hCoV-EMC is most closely related to coronaviruses from bats, but unlike SARS, this study found that hCoV-EMC can still infect cells from many different species of bats. "This was a big surprise," says Drosten. "It's completely unusual for any coronavirus to be able to do that – to go back to its original reservoir." The virus is also able to infect cells from pigs, indicating that it uses a receptor structure that all these animals have in common. If that receptor is present in mucosal surfaces, like the lining of the lung, it is possible the virus could pass from animals to humans and back again, making animals an ongoing source of the virus that would be difficult or impossible to eliminate.

(Continue . . . )

 


The study should be published online at http://mbio.asm.org/ later today.

 

Meanwhile, Helen Branswell has the following report.

 

Study finds puzzling behaviour of new coronavirus, may hint at pattern of spread

By Helen Branswell, The Canadian Press | Associated Press – 7 hrs ago

TORONTO - A new study reveals that the new SARS-like virus which has been causing infections in the Middle East behaves unusually in laboratory testing

(Continue . . . )